Assessment of medical device regulator COVID-19 policies on entry to market for prioritised devices: a case study
<strong>Background/Aims<br></strong> In response to the COVID-19 pandemic, medical devices were given exceptional use authorisations. Medical device regulators around the world modified their administrative approach to medical device approval to ensure that relevant devices and per...
Main Authors: | Bergmann, J, Ceross, A |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
Mark Allen Healthcare
2023
|
פריטים דומים
-
Evaluating the presence of software-as-a-medical-device in the Australian Therapeutic Goods Register
מאת: Ceross, A, et al.
יצא לאור: (2021) -
More than red tape: exploring complexity in medical device regulatory affairs
מאת: Yu Han, et al.
יצא לאור: (2024-07-01) -
More than red tape: exploring complexity in medical device regulatory affairs
מאת: Han, Y, et al.
יצא לאור: (2024) -
Tracking the presence of software as a medical device in US Food and Drug Administration databases: Retrospective data analysis
מאת: Ceross, A, et al.
יצא לאור: (2021) -
Tracking the Presence of Software as a Medical Device in US Food and Drug Administration Databases: Retrospective Data Analysis
מאת: Aaron Ceross, et al.
יצא לאור: (2021-11-01)